학술논문

Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys
Document Type
article
Source
JAMA. 321(3)
Subject
Digestive Diseases
Clinical Trials and Supportive Activities
Cancer
Clinical Research
Prevention
Pediatric
Nutrition
Liver Disease
Chronic Liver Disease and Cirrhosis
Evaluation of treatments and therapeutic interventions
6.7 Physical
Oral and gastrointestinal
Cardiovascular
Metabolic and endocrine
Good Health and Well Being
Adolescent
Blood Glucose
Body Mass Index
Child
Diet
Carbohydrate-Restricted
Dietary Sugars
Hispanic or Latino
Humans
Lipids
Liver Function Tests
Male
Non-alcoholic Fatty Liver Disease
Treatment Outcome
Weight Loss
Medical and Health Sciences
General & Internal Medicine
Language
Abstract
ImportancePediatric guidelines for the management of nonalcoholic fatty liver disease (NAFLD) recommend a healthy diet as treatment. Reduction of sugary foods and beverages is a plausible but unproven treatment.ObjectiveTo determine the effects of a diet low in free sugars (those sugars added to foods and beverages and occurring naturally in fruit juices) in adolescent boys with NAFLD.Design, setting, and participantsAn open-label, 8-week randomized clinical trial of adolescent boys aged 11 to 16 years with histologically diagnosed NAFLD and evidence of active disease (hepatic steatosis >10% and alanine aminotransferase level ≥45 U/L) randomized 1:1 to an intervention diet group or usual diet group at 2 US academic clinical research centers from August 2015 to July 2017; final date of follow-up was September 2017.InterventionsThe intervention diet consisted of individualized menu planning and provision of study meals for the entire household to restrict free sugar intake to less than 3% of daily calories for 8 weeks. Twice-weekly telephone calls assessed diet adherence. Usual diet participants consumed their regular diet.Main outcomes and measuresThe primary outcome was change in hepatic steatosis estimated by magnetic resonance imaging proton density fat fraction measurement between baseline and 8 weeks. The minimal clinically important difference was assumed to be 4%. There were 12 secondary outcomes, including change in alanine aminotransferase level and diet adherence.ResultsForty adolescent boys were randomly assigned to either the intervention diet group or the usual diet group (20 per group; mean [SD] age, 13.0 [1.9] years; most were Hispanic [95%]) and all completed the trial. The mean decrease in hepatic steatosis from baseline to week 8 was significantly greater for the intervention diet group (25% to 17%) vs the usual diet group (21% to 20%) and the adjusted week 8 mean difference was -6.23% (95% CI, -9.45% to -3.02%; P